Type 1 diabetes reversed in lab experiment. 26 March 2021 An experimental treatment could reverse type 1 diabetes for millions of people, helping them regenerate their own insulin-producing capacity and restore their normal blood glucose balance. Type 1 diabetes is an autoimmune condition in which the immune system is actively destroying the cells in the pancreas which produce insulin. The University of Utah Health scientists found that giving mice a single dose of a human antibody that suppress the actions of glucagon, a hormone involved in glucose regulation, led to an incredible transformation in the pancreas. It suppressed the symptoms of diabetes and increased insulin cell mass by seven times. “These animals go from requiring insulin injections to never requiring a diabetes treatment again. They maintain normal blood glucose long after we stop the treatment,” says William L Holland the study’s corresponding author. “What this implies for millions of people who have type 1 diabetes is that there is a chance we could eventually regenerate their own insulin-producing capacity, restore their normal blood glucose balance, and hopefully help make progress toward being free of the disease.” But researchers say they are still a long way from finding a cure. “This research is certainly promising, but it is likely just the first step of many before we can determine if this approach will work in humans with type 1 diabetics,” Holland says. The study has been published in the Proceedings of the National Academy of Sciences (PNAS). You can read more here.
Partners 28 November 2023 Dexcom G6 Continuous Glucose Monitoring (CGM) – For people living with Type 1, Type 2 and Gestational Diabetes*Trial now for only $32.10!† Advertisement ALWAYS READ THE LABEL AND FOLLOW THE DIRECTIONS FOR USE. Read the warnings available on dexcom.com/downloadsandguides before purchasing. Consult... Continue Reading
Partners 28 November 2023 Glucose readings every minute for you† and your loved ones* Advertisement The latest version of the FreeStyle LibreLink app† now allows you to receive continuous glucose readings on your phone,... Continue Reading
Media releases 24 November 2023 New vitamin C diabetes research announced Deakin University’s Professor Glenn Wadley is a recipient of one of this year’s Diabetes Australia Research Program (DARP) grants to study the efficacy of vitamin C in the treatment of foot ulcers in people living with diabetes, which can lead to amputations. Continue Reading